According to G1 Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 04:54 PM, company Director, Muir Glenn P disclosed buying 50,000 shares at a cost of $13.50. At the time of this transaction (Nov 18), this trade was worth $675,000 in total. As […]
According to Organogenesis Holdings Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 04:53 PM, company Director, Ades Alan A. disclosed buying 486,000 shares at a cost of $3.25. At the time of this transaction (Nov 17), this trade was worth $1,579,500 in total. As […]
According to Organogenesis Holdings Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 04:53 PM, company Director, Ades Alan A. disclosed buying 347,153 shares at a cost of $3.25. At the time of this transaction (Nov 17), this trade was worth $1,128,247 in total. As […]
According to Coherus Biosciences, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 04:16 PM, company Chief Operating Officer, Anicetti Vincent R disclosed selling 4,283 shares at a cost of $18.00. At the time of this transaction (Nov 18), this trade was worth $77,094 in […]
According to Keros Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 04:40 PM, company Director, Nussbaum Ran disclosed buying 60,000 shares at a cost of $50.00. At the time of this transaction (Nov 17), this trade was worth $3,000,000 in total. As of […]
According to Coherus Biosciences, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 04:16 PM, company Chief Operating Officer, Anicetti Vincent R disclosed selling 18,487 shares at a cost of $17.66. At the time of this transaction (Nov 17), this trade was worth $326,416 in […]
According to Keros Therapeutics, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 04:39 PM, company Director, Kariv Tomer disclosed buying 60,000 shares at a cost of $50.00. At the time of this transaction (Nov 17), this trade was worth $3,000,000 in total. As of […]
According to Ceridian Hcm Holding Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 04:18 PM, company Chairman and CEO, Ossip David D disclosed selling 506,991 shares at a cost of $94.90. At the time of this transaction (Nov 18), this trade was worth $48,113,446 […]
According to Hyatt Hotels Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 04:16 PM, company See Remarks, Vondrasek Mark R disclosed selling 679 shares at a cost of $71.09. At the time of this transaction (Nov 18), this trade was worth $48,270 in total. […]
According to National Holdings Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Nov 19 04:38 PM, company 10% Owner, Asher Daniel disclosed buying 20,769 shares at a cost of $2.69. At the time of this transaction (Nov 17), this trade was worth $55,879 in total. As […]
PayPal Withdrawing Support For Kindle Fire, BlackBerry And Windows Phone
Revival Of Nashville Discussed
Brawl Erupts After Jose Bautista Downed By Rougned Odor Punch
VR Tour Offered Three Decades After Chernobyl Disaster
Kyle Busch Sweeps NASCAR Events At Martinsville
Halle Berry Enters The Social Media World
